CARRA reports it has completed enrollment of 403 newly diagnosed polyarticular JIA patients in STOP-JIA (Start Time Optimization of Biologic Therapy in Polyarticular JIA). Results anticipated in late 2019. https://t.co/V2qvZCRXvs